Select Page
Novo presents liraglutide data showing 8 pct weight loss

Novo presents liraglutide data showing 8 pct weight loss

Novo presents liraglutide data showing 8 pct weight loss May 16 (Reuters) – Danish drugmaker Novo Nordisk said results from the largest trial of its experimental obesity treatment liraglutide showed an 8 percent weight loss compared to 2.6 percent with placebo...